Becton Dickinson and Co at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Welcome to the next session here. I'm Matt Taylor, UBS' medical supplies and devices analyst, and I'm pleased to finally be talking about something I know something about. This is great.
We thought this would be kind of a cool transition actually for the conference. Obviously, the first half is focused mainly on genomics and life science tools and tomorrow will be a lot of med tech, and we have Becton kind of in the middle.
And to help us make that transition. We have leaders from the Life Sciences group, including Dave Hickey, who's EVP and President of Life Sciences; and Puneet Sarin, the President of Biosciences; and also Kristen Stewart, Head of Strategy and Investor Relations.
And so for this session, we're going to have a short presentation, and then we'll do a fireside chat Q&A. And as always, if you want to ask questions, you can just key in with the instructions on your tables.
So without further ado, let me introduce, well, Kristen
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
